Generation and profiling of fully human HuCAL gold-derived therapeutic antibodies specific for human CD38 | Patent Number 11939395

US 11939395 B2
Application Number17343163
Publication NumberUS 20210292431 A1
Pendency2 years, 9 months, 21 days
Filled DateJun 9, 2021
Priority Date-
Publication DateSep 23, 2021
Expiration DateJun 8, 2041
Inventor/ApplicantsMichael TESAR
Ute JAGER
Ute Jager
Michael Tesar
ExaminesREDDIG, PETER J
Art Unit1642
Technology Center1600
Assignments
Morphosys Ag
Current
Morphosys Ag
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.